473
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Effect of terazosin on sweating in patients with major depressive disorder receiving sertraline: A randomized controlled trial

, , &
Pages 44-47 | Received 06 Sep 2011, Accepted 16 Apr 2012, Published online: 26 Jun 2012

References

  • Koenig AM, Thase ME. First-line pharmacotherapies for depression – what is the best choice? Pol Arch Med Wewn 2009;119:478–86.
  • Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. J Am Med Assoc 2002;287:203–9.
  • Demling J, Beyer S, Kornhuber J. To sweat or not to sweat? A hypothesis on the effects of venlafaxine and SSRIs. Med Hypotheses 2010;74:155–7.
  • Ashton AK, Weinstein WL. Cyproheptadine for drug-induced sweating. Am J Psychiatry 2002;159:874–5.
  • Babbott SF, Pearson VE. Sertraline-related night sweats. Ann Intern Med 1999;130:242–3.
  • Kiev A, Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry 1997;58:146–52.
  • Keller MB, Hirschfeld RM, Demyttenaere K, Baldwin DS. Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol 2002;17:265–71.
  • Kim WO, Kil HK, Yoon KB, Yoo JH. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients. Acta Derm Venereol 2010;90:291–3.
  • Sadock BJ. Biological therapies Kaplan & Sadock’s Synopsis of psychiatry. 10th ed. Boston, MA: Wolters Kluwer, Lippincott Williams & Wilkins; 2007. p. 1083–91.
  • Garber A, Gregory RJ. Benztropine in the treatment of venlafaxine-induced sweating. J Clin Psychiatry 1997;58:176–7.
  • Tupker RA, Harmsze AM, Deneer VH. Oxybutynin therapy for generalized hyperhidrosis. Arch Dermatol 2006;142: 1065–6.
  • Kowalski JW, Eadie N, Daggett S, lai PY. Validity and reliability of the Hyperhidrosis Disease Severity Scale (HDSS). In: 62nd Annual Meeting of the American Academy of Dermatology. Washington, DC. Poster P198, 6–10 February 2004.
  • Stahl SM. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biol Psychiatry 2000;48:894–901.
  • Mago R, Monti D. Antiadrenergic treatment of antidepressant-induced excessive sweating in 3 patients. J Clin Psychiatry 2007;68:639–40.
  • Feder R. Clonidine treatment of excessive sweating. J Clin Psychiatry 1995;56:35.
  • Leeman CP. Pathophysiology of tricyclic-induced sweating. J Clin Psychiatry 1990;51:258–9.
  • Butt MM. Managing antidepressant-induced sweating. J Clin Psychiatry 1989;50:146–7.
  • Salmi P, Ahlenius S. Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms. Pharmacol Toxicol 1998;82:122–7.
  • Speroff L, Gass M, Constantine G, Olivier S. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol 2008;111:77–87.
  • Medgett IC, Fearn HJ, Rand MJ. Serotonin enhances sympathetic vasoconstrictor responses in rat isolated perfused tail artery by activation of postjunctional serotonin-2 receptors. Clin Exp Pharmacol Physiol 1984;11:343–6.
  • Ramage AG, Villalon CM. 5-hydroxytryptamine and cardiovascular regulation. Trends Pharmacol Sci 2008;29:472–81.
  • Terazosin: Drug information. UpToDate Waltham, MA: UpToDate; 2011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.